About Broadstreet HEOR
We are an independent consultancy specializing in epidemiology and health economics, with a particular focus on creating customized solutions to best meet our clients’ diverse needs. Our team comprises of epidemiologists, health economists, statisticians, and IT specialists. Our projects are led by senior team members with extensive experience leading the kinds of HEOR studies at which Broadstreet excels. We have a ready pool of clinical collaborators and data holders for real-world studies; and offer a package of integrated service offerings with our core areas of expertise:
Economic models grounded in robust, realist evidence synthesis
Epidemiologic and statistical modelling
Quantitative and qualitative patient and physician interviews
We work well with others
We are not a large company with an interchangeable and revolving roster. We are a small office, the core of which has worked together for more than 15 years. We enjoy working with each other and pride ourselves on our strength in collaborating with others. We conduct business on human terms, not term sheets.
We only do work we’re best at
We focus on what we know how to do very well. We specialize in building economic models, conducting literature reviews and evidence syntheses, designing and implementing database studies, and conducting retrospective and prospective observational studies and surveys focusing on epidemiology, treatment patterns, outcomes and preferences. In addition, we have created a number of customizable mobile applications to help clients demonstrate the value of their products.
We’re honest and transparent
Project management and scientific rigour — clients tell us we’ve mastered what is both art and science. We’re honest and transparent right from project definition stage through to completion. We keep open lines of communication. We include the client as part of our project team. Most importantly, we do not believe in Big Surprises.
We’re invested in whom we work with
We really care about our projects – it’s the first thing we tell anyone we work with, and that is what we hear back from them. We have very many long standing relationships with clients that are important to us. And with new clients, we ensure we give each project the attention it deserves, so they want to work with us again.
We deliver as promised
Clients trust us. Our client service approach is simple: whatever the problem, no matter how difficult or time constrained, we will have a rigorous solution and deliver – as promised.
We are a small office, the core of which has worked together in HEOR for more than 15 years. We enjoy working with each other and pride ourselves on our strength in collaborating with others. We conduct business on human terms, not term sheets.
Our larger team comprises epidemiologists, health economics, biostatisticians, and programmers. Specifically, this includes research directors, a senior business director, systematic reviewers and analysts. We also have an in-house data services team that includes database administrators, programmers, and an interface designer.
Meet our key team members
CEO and Scientific Director
For me, the perfect fit is a small business consultancy framework where I can work closely with colleagues I enjoy, and clients I like, on interesting research projects. I’m trained in epidemiology and have 15 years of experience in health outcomes research and consulting. Prior to Broadstreet, I was a Principal at ICON plc and the Head of the Epidemiology team; and the Head of Evidence Generation at Redwood Outcomes. My research interests are in pharmacoepidemiology, observational studies, burden of illness, preferences and methodologies to estimate competing benefits and risks. I’ve conducted studies in the areas of oncology, infectious diseases, rheumatology, diabetes, pediatrics, ophthalmology, and pain management; and my work has been published in journals including the Journal of Pediatrics, Annals of Hepatology, Arthritis & Rheumatism, British Journal of Cancer, Investigative Ophthalmology & Visual Sciences, Clinical Pediatrics, and Value in Health. In addition to the scientific aspect of our work, I also like the business aspects; including leading the research team, liaising with existing and potential clients, developing and implementing new initiatives that can meet our clients’ needs, and ultimately ensuring our clients’ satisfaction.
Karissa Johnston, PhD
Principal and Scientific Director
I love working as a consultant in HEOR. I enjoy the fast pace, the variety of studies we have a chance to work on, the ongoing collaborations with clients and experts, and the ability to maintain a “hands-on” role in academic research and analysis. I have a MSc. in statistics and a PhD in epidemiology. In addition to my full-time role as a Principal at Broadstreet, I have an adjunct appointment at Memorial University. As a consultant, my experience includes the development of cost-effectiveness and budget impact models; analysis of administrative, chart review, and trial data; retrospective study design; evidence synthesis; and patient preference studies such as discrete choice experiments. I have worked across a wide range of therapeutic areas, and have published articles in journals such as AIDS, Lancet Infectious Diseases, BMC Pediatrics, the European Journal of Cancer, and Value in Health.
Principal and Managing Director
My skill set is to create and sustain organizations that empower employees to serve clients. Over the last 25 years, I have been helping public and private organizations grow and succeed this way. After several senior management positions, I have returned to my preferred setting: leading a small HEOR company made up of people I count as both friends and colleagues. As a senior health services and health research leader and manager, I have years of executive, P&L and M&A responsibility. I have formal education in Business and community health and health services administration.
Yesterday, Broadstreet’s Karissa Johnston was asked by the CBC to comment on a new study that suggested that some commonly prescribed drugs could have adverse events leading to depression or even suicide. The study (which nether Karissa nor Broadstreet were […]
The development of software tools that enable the presentation of data visually and interactively is significantly changing the way we communicate and engage with the results of HEOR and epidemiology studies. To date this change has largely focused on visualizing […]
For Broadstreet, transparent communication with the client through all stages of a project is a principle tenet and we see clear and effective visualization of a study’s results as a core part of that. One type of data visualization tool […]